Arthur P. Bollon Photo
Arthur P. Bollon
SignPath Pharma
Philadelphia
Biography
Presently: Director, Co-Founder of SignPath Pharma, developing Curcumin for treatment of cancer. Founder, Chairman & CEO of VITRUVIAN BioMedical, Inc. which is developing an Alzheimer Disease Blood Test and Therapeutic Vaccine. First company founded was Wadley Biosciences/LPL which was a joint venture between Wadley Institutes and Phillips Petroleum with focus on cancer and infectious disease, 1987-1992. The second company founded was Cytoclonal Pharmaceutics, which went public with an IPO in 1995, and entered into a licensing agreement with Bristol Myers on Taxol production, and was merged to create OPKO Health. Former Chairman & CEO of HemoBioTech, Inc., developing HemoTech as viable substitute for human red blood cells.
Role
OCM
5th International Conference on Neurology and Neuroimmunology
Research Interests
Neurology, Neuro-degenerative diseases

Upcoming Events
View All

Copyright © 2017-2018 Allied Academies, All Rights Reserved.